AKTS Earnings
Friday, May 08 2026
EPS Estimate
$-0.33
$-0.36 – $-0.27
Revenue Estimate
$2M
Current Price
$22.00
Our Position
bullish · highSix insiders buy $114M at $18 each
structured data
est. revisions stable
The concentrated insider buying at a low stock price while maintaining high cash reserves indicates potential catalysts or undervaluation, attracting institutional confidence despite significant losses.
Watch: Watch upcoming clinical updates or FDA decisions that could validate insider optimism and trigger a re-rating toward analyst targets.
Data Signal Summary
2 bullish
1 bearish
Estimates up +3%
Insider buying cluster
Price downtrend
Key Context
Insider Activity
buying
Price Trend
downtrend
From 52w High
0.0%
Est. Revisions (30d)
+2.9% 1up/0dn
Analyst Target (mean)
$32 $30–$34 +48%
Est. Dispersion
27% 3 analysts
Insider Cluster
strong buy
Recent Activity
insider trades
13 transactions
Buy
·
GADICKE ANSBERT S. (Beneficial Owner of more than 10% of a Class of Security)
·1,112,777 shares
·$20,029,986
Other
·
GADICKE ANSBERT S. (Beneficial Owner of more than 10% of a Class of Security)
·8,805,578 shares
Other
·
SEGAL LLOYD MITCHELL (Director)
·19,631 shares
Buy
·
FOLEY TODD (Director and Beneficial Owner of more than 10% of a Class of Security)
·232,870 shares
·$4,191,660
Other
·
FOLEY TODD (Director and Beneficial Owner of more than 10% of a Class of Security)
·4,002,533 shares
8 more
Buy
·
KIM HELEN SUSAN
·835,000 shr
·$15,030,000
Other
·
KIM HELEN SUSAN
·4,994,212 shr
Buy
·
MPM BIOVENTURES 2018, L.P.
·1,112,777 shr
·$20,029,986
Other
·
MPM BIOVENTURES 2018, L.P.
·8,805,578 shr
Buy
·
ECOR1 CAPITAL, L.L.C.
·2,222,222 shr
·$39,999,996
Other
·
ECOR1 CAPITAL, L.L.C.
·2,602,247 shr
Buy
·
VIDA VENTURES II, L.L.C
·835,000 shr
·$15,030,000
Other
·
VIDA VENTURES II, L.L.C
·4,994,212 shr
Explore more
